Literature DB >> 29306218

Toddlers at risk for Autism Spectrum Disorders from Kerala, India - A community based screening.

Jaisoorya Ts1, Preeti Jacob2, Shoba Srinath3, Sunil Kumar G4, Manoj L5, Gokul Gr6, Diana L Robins7, Thennarasu K8.   

Abstract

AIMS: To study the at-risk rate for Autism Spectrum Disorders (ASD) on a parent-report questionnaire in toddlers between the ages of 16-24 months.
MATERIALS AND METHODS: 6237 toddlers from Kerala, India selected by cluster random sampling were surveyed by community nurses using the Modified Checklist for Autism in Toddlers - Revised (M-CHAT-R) translated to Malayalam and culturally adapted.
RESULTS: 5.5% toddlers were at risk on M-CHAT-R and 2.7% on "Best Seven".
CONCLUSIONS: M-CHAT-R and its "Best Seven" could be viable community level screening instruments, albeit with further cultural adaptation for a primarily non-English speaking population in India.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autism Spectrum Disorders; India; M-CHAT-R; Screening; Toddlers

Mesh:

Year:  2017        PMID: 29306218     DOI: 10.1016/j.ajp.2017.12.016

Source DB:  PubMed          Journal:  Asian J Psychiatr        ISSN: 1876-2018


  3 in total

1.  Acinar Cell Cystadenoma of the Pancreas: a Multidisciplinary and Contemporary Approach.

Authors:  Sabrina C Sopha; J H Terhune; L Hoover; L Uradomo; C N Boutros
Journal:  J Gastrointest Surg       Date:  2018-01-29       Impact factor: 3.452

2.  Early Social Experience and Digital-Media Exposure in Children with Autism Spectrum Disorder.

Authors:  Vaisakh Krishnan; Padinharath Krishnakumar; V K Gireeshan; Biju George; Salah Basheer
Journal:  Indian J Pediatr       Date:  2021-01-20       Impact factor: 1.967

3.  To assess the magnitude of autism spectrum disorder in Jharkhand by M-CHAT-R as a screening tool.

Authors:  Apeksha Pathak; Naghma Mobin; Kamal N Prasad; Kalpak Mondal; Olie Mitra; Abhinandan Kumar; Harshwardhana Sinha
Journal:  J Family Med Prim Care       Date:  2022-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.